Skip to main content
Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
460.00
+15.10 (3.39%)
Apr 29, 2026, 10:15 AM IDT

Can-Fite BioPharma Revenue

In the year 2025, Can-Fite BioPharma had annual revenue of $405.00K USD, down -39.91%. Can-Fite BioPharma had revenue of $203.00K in the half year ending December 31, 2025, a decrease of -42.17%.

Revenue
$405.00K
Revenue Growth
-39.91%
P/S Ratio
14.77
Revenue / Employee
$81.00K
Employees
5
Market Cap
19.06M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025405.00K-269.00K-39.91%
Dec 31, 2024674.00K-69.00K-9.29%
Dec 31, 2023743.00K-67.00K-8.27%
Dec 31, 2022810.00K-43.00K-5.04%
Dec 31, 2021853.00K90.00K11.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioLight Life Sciences 21.00K
XTL Biopharmaceuticals 3.26M
Evogene 12.28M
BioLineRx 3.76M
Clal Biotechnology Industries 11.55M
Geffen Residence & Renewal 78.00K
Revenue Rankings

Can-Fite BioPharma News

More News